INVIVYD, INC.

IVVD

CIK 0001832038 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$17M
↑+24.5% +$3Mvs FY2024 (Q4)
Gross Profit
$17M
↑+24.5% +$3Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
51/100
  • Profitability
    0ROIC -28.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 7.24 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    5Asset Turnover 0.26x (1.0+ = capital-efficient)
  • Growth
    98Revenue YoY +24.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -84.0% · trend +1302.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$155K
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$277M
everything owned
Total liabilities
$35M
everything owed
Stockholders' equity
$242M
shareholder claim

Recent performance · 23 quarters

Revenue↑+24.5% +$3M
$17M
Net Income↑+82.8% +$50M
$-10M
Free Cash Flow
$0
Operating Margin↑+586.1pts
-84.0%

Drill down